Use of natriuretic peptides in pre-participation screening of college athletes

International Journal of Cardiology

Volumn 124, Issue 3, 2008, Pages 411-414

  Daniels, Lori B ^a,b   Allison, Matthew A ^a   Clopton, Paul ^b   Redwine, Laura ^b   Siecke, Neil ^a   Taylor, Kenneth ^a   Fitzgerald, Robert ^a,b   Bracker, Mark ^a   Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Athletes; Hand held echocardiography; Natriuretic peptides; Pre participation screening

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BLOOD ANALYSIS; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RUNNING; SCREENING;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MASS SCREENING; NATRIURETIC PEPTIDES; PREVALENCE; RISK FACTORS; SPORTS; UNITED STATES;

EID: 39749191924     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.12.076     Document Type: Article

References (7)

1. Pfister G.C., Puffer J.C., and Maron B.J. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA 283 (2000) 1597-1599
2. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., and Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276 (1996) 199-204
3. Fuller C.M. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 32 (2000) 887-890
4. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
5. Struthers A.D. Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart 87 (2002) 97-98
6. Mueller T., Gegenhuber A., Poelz W., and Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 341 (2004) 41-48
7. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663